SanoGene Theraputics Overview

  • Founded
  • 2006

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

SanoGene Theraputics General Information


Developer of biopharmaceutical products designed to prevent deadly cancers. The company's biopharmaceutical products utilize innovative RNAi-based technologies that combines the capabilities of multiple therapeutics into one deliverable product with synergistic effects, enabling patients to avail next generation of cancer treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Chicago, IL
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SanoGene Theraputics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jun-2016 00000 Completed Out of Business
2. Seed Round 26-May-2009 00000 00000 Completed Startup
1. Grant 01-Nov-2006 $86K Completed Startup
To view SanoGene Theraputics’s complete valuation and funding history, request access »